Pediatric Urinary Tract Infection Workup
- Author: Donna J Fisher, MD; Chief Editor: Russell W Steele, MD more...
Approach Considerations
Good clinical and experimental data support the opinion that the best way to prevent kidney damage due to a urinary tract infection (UTI) is through prompt diagnosis and effective treatment of a febrile UTI.
The diagnosis of UTI is based on the quantitative culture of a properly collected urine specimen. A midstream, clean-catch specimen may be obtained from children who have urinary control. In the infant or child unable to void on request, the specimen for culture should be obtained by means of suprapubic aspiration or urethral catheterization.
Suprapubic aspiration is also the method of choice for obtaining urine from uncircumcised boys with a redundant or tight foreskin and from children of either sex with clinically significant periurethral irritation.
A culture of a urinary specimen from a sterile bag attached to the perineal area that shows no or scant growth (< 10,000 colony-forming units [CFUs]/mL) is strong evidence that UTI is absent. However, the false-positive rate is so high that this method of urine collection is not suitable for diagnosing UTI.[5]
As a means of documenting the presence of UTI, urinalysis is not a substitute for urine culture. However, it can help in identifying those febrile children who should receive antibacterial treatment while culture results from a properly collected urine specimen are pending.
Numerous studies have compared dipstick tests for leukocyte esterase and nitrite with microscopic examination of the urinary sediment for bacteria with urine culture. These studies have been performed to determine whether the dipstick test can eliminate the need for urine culture. The invasiveness, time involved, and cost of the culture could be eliminated.
Studies report that the specific components of the dipstick test and complete urinalysis cannot detect positive culture findings in all children who have positive urine culture findings and unexplained fever or voiding symptoms. The conclusion is that urine should be obtained for culture, and initial treatment should be given to those children with fever and a presumptive diagnosis of a UTI, regardless of the result of urinary dipstick testing or urinalysis.[6, 7, 8, 9, 10, 11, 12]
A study by Lunn et al supports the use of automated microscopy for screening urine samples for culture in children.[13] In 280 urine samples collected from 263 pediatric patients, automated microscopy performed comparably to urine dipstick in the diagnosis of UTI; automated microscopy had better specificity and likelihood ratios than dipstick testing, but it had slightly lower sensitivity.
Hematologic studies do not tend to help in the diagnosis of UTIs, although they should be obtained in patients who appear ill. In patients with suspected bacteremia or urosepsis, blood cultures should be obtained.
Renal function can be measured by serum creatinine and BUN (blood urea nitrogen) levels and may be elevated in severe disease. Moreover, electrolyte abnormalities may be present in UTI.
Procalcitonin, a propeptide of calcitonin that has been found to be elevated in response to bacterial endotoxins, has shown promise in helping to diagnosis pyelonephritis and early renal damage.[14, 15, 16, 17]
Obtain a complete blood count (CBC) and basic metabolic panel for children with a presumptive diagnosis of pyelonephritis. Perform blood cultures in febrile infants and older patients who are clinically ill, toxic, or severely febrile.
Imaging
The American Academy of Pediatrics recommends that all infants and young children (aged 2mo to 2y) with a first UTI undergo urinary tract ultrasonography and voiding cystourethrography (VCUG). These tests should be acquired promptly if patients fail to show expected clinical response within 2 days of treatment.[5]
If imaging studies of the urinary tract are warranted, they should not be obtained until the diagnosis is confirmed with a quantitative urine culture. The following types of pediatric patients do not need imaging studies after a first UTI:
- Infants and children with a first febrile UTI who are assured follow-up, who respond promptly to treatment (afebrile within 72 h), and who have a normal voiding pattern (no dribbling) and no abdominal mass
- Infants and children with cystitis
With regard to the second above item, children with an abnormal voiding pattern after receiving effective treatment of the UTI may need to undergo an evaluation for voiding dysfunction; this may include standard VCUG.
Urine Collection and Analysis
The criterion standard for diagnosing urinary tract infections (UTIs) is the isolation of a pathogen from a urine culture obtained via suprapubic aspiration.[18] However, catheterization, rather than aspiration, is the most commonly used collection technique in infants and younger children.
Midstream clean-catch urine specimens are adequate for older children who can provide them. More than 100,000 CFU/mL in a midstream clean-catch urine specimen is defined as a UTI.
Due to high rates of false positives, bagged urine specimens are of no value in the diagnosis of UTIs, and their use should be discouraged.
Because it may take as long as 48 hours for a urine culture to be positive, urinalysis is often needed to help make the initial diagnosis of UTI. A urine specimen that is found to be positive on dipstick for nitrite, leukocyte esterase, or blood may indicate a UTI. Dipstick tests have sensitivities approaching 85-90%.
Microscopic examination of spun urine can evaluate for the presence of white blood cells (WBCs), red blood cells (RBCs), bacteria, casts, and skin contamination (eg, epithelial cells).
With regard to suprapubic aspirate, the presence of 5 or more WBCs/high-power field suggests an infection. The presence of 10 or more WBCs/μL is also consistent with infection.[19, 20] Gram stain of unspun urine obtained via suprapubic aspirate may reveal organisms.
A hemacytometer measures cells per volume and has been found to be more sensitive and specific than standard microscopic examination.[19, 20] A combination of hemacytometer cell count and Gram stain has been shown in studies to have a sensitivity approaching 95%.
In pediatric patients, urine cultures should be sent to the laboratory even if urinalysis results are inconclusive. Approximately 10-20% of pediatric patients with UTI have normal urinalysis results. Multiple organisms may be present if structural abnormalities exist.
Methods of urine collection and examination, as well as salient findings, are shown in tables 1 and 2.
Table 1. Urinalysis for Presumptive Diagnosis of Urinary Tract Infection* (Open Table in a new window)
| Method | Findings |
| Bright-field or phase-contrast microscopy of centrifuged urinary sediment | Bacteria |
| Gram stain of uncentrifuged or centrifuged urinary sediment | Bacteria |
| Nitrite and leukocyte esterase test | Positive = UTI likely |
| Nitrite test | Positive = UTI probable |
| Leukocyte esterase test | Positive = Nonspecific |
| *Negative microscopic findings for bacteria do not rule out a UTI, nor do negative results of dipstick testing for nitrite and leukocyte esterase. | |
Table 2. Quantitative Urine Culture for the Diagnosis of Urinary Tract Infection* (Open Table in a new window)
| Method | Finding |
| Suprapubic aspiration | If a UTI is present, bacteria are likely to be proliferating in bladder urine, with growth of any organism except 2000-3000 CFU/mL coagulase-negative staphylococci. |
| Catheterization in a girl or midstream, clean-void collection in a circumcised boy | Febrile infants and children with UTI usually have >50,000 CFU/mL of a single urinary pathogen; however, UTI may be present with 10,000-50,000 CFU/mL of a single organism.* |
| Midstream, clean-void collection in a girl or uncircumcised boy | UTI is indicated when >100,000 CFU/mL of a single urinary pathogen is present in a symptomatic patient. Pyuria usually present. A UTI may be present with 10,000-50,000 CFU/mL of a single bacterium.* |
| Any method in a girl or boy | If the patient is asymptomatic, bacterial growth is usually >100,000 CFU/mL of the same organism on different days. If pyuria is absent, this result probably indicates colonization rather than infection. |
| *Patients with urinary frequency (ie, decreased bladder incubation time) are those most likely to have bacteria proliferating in the urinary bladder in the presence of low colony counts. | |
Ultrasonography
Ultrasonography of the urinary tract has replaced the use of intravenous pyelography (IVP). However, studies have shown that ultrasonograms of the urinary tract obtained after a first febrile urinary tract infection (UTI) seldom provide information that changes management. Nonetheless, the American Academy of Pediatrics Clinical Practice Guidelines recommend routine ultrasonography after a first febrile UTI in children aged 2-24 months.[5]
However, a current recommendation is that urinary ultrasonography be omitted after a first febrile UTI in infants and children if they respond to treatment (afebrile within 72h), good follow-up is assured, and no voiding abnormality (no dribbling of urine) or abdominal mass is present.
The clinician's judgment should guide the decision regarding imaging studies, as opposed to a rigid rule. Urinary ultrasonography is a safe, noninvasive study that is easy to perform. It is useful in excluding obstructive uropathy and in identifying children with a solitary or ectopic kidney and some patients with moderate renal damage caused by pyelonephritis.[21]
Recommendations
Febrile infants aged 2-24 months with UTI should undergo renal and bladder ultrasonography.[5] In addition, the following pediatric patients should also undergo ultrasonography of the urinary tract after a febrile UTI:
- Children with a delayed or unsatisfactory response to treatment of the first febrile UTI
- Children with an abdominal mass or abnormal voiding (dribbling of urine)
- Children with a first febrile UTI caused by an organism other than E coli
- Children with recurrence of a febrile UTI after they have had a satisfactory response to treatment of the initial febrile UTI
Renal ultrasonography should also be considered for any child with a first febrile UTI in whom good follow-up cannot be ensured.
Voiding Cystourethrography
Traditionally, VCUG has been recommended for infants and children after a first febrile UTI. This is based on the assumptions that most upper UTIs occur because of urinary bladder infection and that vesicoureteral reflux (VUR) transfers bacteria in the bladder to the kidney. However, using cortical imaging, current data show that upper tract infection occurs equally in children with or without VUR.
VCUG is indicated if renal and bladder ultrasonography reveals hydronephrosis, scarring, or other findings that suggest either high-grade VUR or obstructive uropathy. VCUG should be performed if there is a recurrence of a febrile UTI, even if previous ultrasonographic examination findings were unremarkable.[5]
The assumption that antibacterial prophylaxis prevents a recurrence of UTI seems reasonable, although this has not been proven. However, a review of literature published since 2005 suggested that the risk of developing long-term complications after a UTI is extremely low, that imaging should be used only in a select group of children at risk, and that the use of antibiotic prophylaxis remains questionable.[22] Because data do not support the use of antimicrobial prophylaxis to prevent febrile recurrent UTI in infants with no VUR or with grade I-IV VUR, VCUG is not recommended routinely after the first UTI.[5]
Of note, a first febrile UTI is as frequent in infants with VUR as in those without radiographically demonstrated reflux. The recommendation for VCUG after a first febrile UTI is based on expert opinion and judgment, not on evidence-based guidelines.
Some experts suggest that cystography that requires catheterization of the urinary bladder be avoided. Their recommendation, which is not evidence based, is that renal cortical scanning (renal scintigraphy) should be performed. This study helps in identifying kidney injury and/or pyelonephritis. If the scan findings are normal, cystography is not needed. However, if the results are abnormal, VCUG should be obtained.
If a VCUG is to be obtained, it should be obtained after the voiding pattern returns to its pre-UTI state. If the organism that caused the UTI was susceptible to the antibacterial used to treat the febrile UTI and if the response to therapy was satisfactory, follow-up urinalysis or cultures are not needed. The child should receive antibacterial therapy at least until the cystogram is obtained.
Some clinicians recommend waiting 4-6 weeks after febrile UTI is treated to perform VCUG. If the child is given suppressive antibacterial treatment during this period, this recommendation is acceptable. However, studies have shown that the VCUG may be obtained within the first few days of treating febrile UTI if the voiding pattern has returned to its pre-UTI state.
Recommendations
The following types of pediatric patients should undergo VCUG after a first febrile UTI:
- Those in whom treatment fails after 48-72 hours
- Patients with an abnormal voiding pattern (dribbling of urine)
- Infants and children in whom good follow-up is not assured
- Those with an abdominal mass
- Infants and children with recurrence of a febrile UTI
Zaffanello M, Malerba G, Cataldi L, Antoniazzi F, Franchini M, Monti E, et al. Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol. 2010;2010:321082. [Medline]. [Full Text].
Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr. Jul 1993;123(1):17-23. [Medline].
Zorc JJ, Levine DA, Platt SL, Dayan PS, Macias CG, Krief W, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics. Sep 2005;116(3):644-8. [Medline].
Shaikh N, Morone NE, Lopez J, Chianese J, Sangvai S, D'Amico F, et al. Does this child have a urinary tract infection?. JAMA. Dec 26 2007;298(24):2895-904. [Medline].
[Guideline] Subcommittee on Urinary Tract Infection; Steering Committee on Quality Improvement and Management. Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months. Pediatrics. Aug 28 2011;[Medline].
Girardet P, Frutiger P, Lang R. Urinary tract infections in pediatric practice. A comparative study of three diagnostic tools: dip-slides, bacterioscopy and leucocyturia. Paediatrician. 1980;9(5-6):322-37. [Medline].
Goldsmith BM, Campos JM. Comparison of urine dipstick, microscopy, and culture for the detection of bacteriuria in children. Clin Pediatr (Phila). Apr 1990;29(4):214-8. [Medline].
Anderson JD, Chambers GK, Johnson HW. Application of a leukocyte and nitrite urine test strip to the management of children with neurogenic bladder. Diagn Microbiol Infect Dis. Jul 1993;17(1):29-33. [Medline].
Craver RD, Abermanis JG. Dipstick only urinalysis screen for the pediatric emergency room. Pediatr Nephrol. Jun 1997;11(3):331-3. [Medline].
Shaw KN, McGowan KL, Gorelick MH, Schwartz JS. Screening for urinary tract infection in infants in the emergency department: which test is best?. Pediatrics. Jun 1998;101(6):E1. [Medline].
Anad FY. A simple method for selecting urine samples that need culturing. Ann Saudi Med. Jan-Mar 2001;21(1-2):104-5. [Medline].
Bachur R, Harper MB. Reliability of the urinalysis for predicting urinary tract infections in young febrile children. Arch Pediatr Adolesc Med. Jan 2001;155(1):60-5. [Medline].
[Best Evidence] Lunn A, Holden S, Boswell T, Watson AR. Automated microscopy, dipsticks and the diagnosis of urinary tract infection. Arch Dis Child. Mar 2010;95(3):193-7. [Medline].
Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol. Jun 2002;17(6):409-12. [Medline].
Nikfar R, Khotaee G, Ataee N, Shams S. Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department. Pediatr Int. Jul 6 2009;[Medline].
Bressan S, Andreola B, Zucchetta P, Montini G, Burei M, Perilongo G, et al. Procalcitonin as a predictor of renal scarring in infants and young children. Pediatr Nephrol. Jun 2009;24(6):1199-204. [Medline].
Ipek IO, Sezer RG, Kinay ES, et al. Relationship between procalcitonin levels and presence of vesicoureteral reflux during first febrile urinary tract infection in children. Urology. Jan 12 2012;[Medline].
Quigley R. Diagnosis of urinary tract infections in children. Curr Opin Pediatr. Apr 2009;21(2):194-8. [Medline].
Lin DS, Huang FY, Chiu NC, Koa HA, Hung HY, Hsu CH, et al. Comparison of hemocytometer leukocyte counts and standard urinalyses for predicting urinary tract infections in febrile infants. Pediatr Infect Dis J. Mar 2000;19(3):223-7. [Medline].
Lin DS, Huang SH, Lin CC, Tung YC, Huang TT, Chiu NC, et al. Urinary tract infection in febrile infants younger than eight weeks of Age. Pediatrics. Feb 2000;105(2):E20. [Medline].
Pennesi M, L'erario I, Travan L, et al. Managing children under 36 months of age with febrile urinary tract infection: a new approach. Pediatr Nephrol. Jan 11 2012;[Medline].
Merguerian PA, Sverrisson EF, Herz DB, McQuiston LT. Urinary tract infections in children: recommendations for antibiotic prophylaxis and evaluation. An evidence-based approach. Curr Urol Rep. Mar 2010;11(2):98-108. [Medline].
Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics. Apr 1999;103(4):e54. [Medline].
Paschke AA, Zaoutis T, Conway PH, Xie D, Keren R. Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children. Pediatrics. Apr 2010;125(4):664-72. [Medline].
Schnadower D, Kuppermann N, Macias CG, et al. Febrile infants with urinary tract infections at very low risk for adverse events and bacteremia. Pediatrics. Dec 2010;126(6):1074-83. [Medline].
Schnadower D, Kuppermann N, Macias CG, et al. Sterile Cerebrospinal Fluid Pleocytosis in Young Febrile Infants With Urinary Tract Infections. Arch Pediatr Adolesc Med. Jul 2011;165(7):635-641. [Medline].
Hoberman A, Keren R. Antimicrobial prophylaxis for urinary tract infection in children. N Engl J Med. Oct 29 2009;361(18):1804-6. [Medline].
Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. Nov 2008;122(5):1064-71. [Medline].
Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. Mar 2006;117(3):626-32. [Medline].
Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. Jun 2008;121(6):e1489-94. [Medline].
Mattoo TK. Are prophylactic antibiotics indicated after a urinary tract infection?. Curr Opin Pediatr. Apr 2009;21(2):203-6. [Medline]. [Full Text].
Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. Oct 29 2009;361(18):1748-59. [Medline].
Williams G, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. Mar 16 2011;3:CD001534. [Medline].
Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol. 2009;43(5):369-72. [Medline].
Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. Jul 1999;104(1 Pt 1):79-86. [Medline].
Weisz D, Seabrook JA, Lim RK. The Presence of Urinary Nitrites Is a Significant Predictor of Pediatric Urinary Tract Infection Susceptibility to First- and Third-Generation Cephalosporins. J Emerg Med. Jul 2010;39(1):6-12.
- Table 1. Urinalysis for Presumptive Diagnosis of Urinary Tract Infection*
- Table 2. Quantitative Urine Culture for the Diagnosis of Urinary Tract Infection*
- Table 3. Antibiotic Agents for Parenteral Treatment of a Urinary Tract Infection
- Table 4. Antibiotic Agents for the Oral Treatment of Urinary Tract Infection
- Table 5. Antibiotic Agents to Prevent Reinfection
| Method | Findings |
| Bright-field or phase-contrast microscopy of centrifuged urinary sediment | Bacteria |
| Gram stain of uncentrifuged or centrifuged urinary sediment | Bacteria |
| Nitrite and leukocyte esterase test | Positive = UTI likely |
| Nitrite test | Positive = UTI probable |
| Leukocyte esterase test | Positive = Nonspecific |
| *Negative microscopic findings for bacteria do not rule out a UTI, nor do negative results of dipstick testing for nitrite and leukocyte esterase. | |
| Method | Finding |
| Suprapubic aspiration | If a UTI is present, bacteria are likely to be proliferating in bladder urine, with growth of any organism except 2000-3000 CFU/mL coagulase-negative staphylococci. |
| Catheterization in a girl or midstream, clean-void collection in a circumcised boy | Febrile infants and children with UTI usually have >50,000 CFU/mL of a single urinary pathogen; however, UTI may be present with 10,000-50,000 CFU/mL of a single organism.* |
| Midstream, clean-void collection in a girl or uncircumcised boy | UTI is indicated when >100,000 CFU/mL of a single urinary pathogen is present in a symptomatic patient. Pyuria usually present. A UTI may be present with 10,000-50,000 CFU/mL of a single bacterium.* |
| Any method in a girl or boy | If the patient is asymptomatic, bacterial growth is usually >100,000 CFU/mL of the same organism on different days. If pyuria is absent, this result probably indicates colonization rather than infection. |
| *Patients with urinary frequency (ie, decreased bladder incubation time) are those most likely to have bacteria proliferating in the urinary bladder in the presence of low colony counts. | |
| Drug | Dosage and Route | Comment |
| Ceftriaxone | 50-75 mg/kg/day IV/IM as a single dose or divided q12h | Do not use in infants < 6wk of age; parenteral antibiotic with long half-life; may displace bilirubin from albumin |
| Cefotaxime | 150 mg/kg/day IV/IM divided q6-8h | Safe to use in infants < 6wk of age; used with ampicillin in infants aged 2-8wk |
| Ampicillin | 100 mg/kg/day IV/IM divided q8h | Used with gentamicin in neonates < 2wk of age; for enterococci and patients allergic to cephalosporins |
| Gentamicin | Term neonates < 7 days: 3.5-5 mg/kg/dose IV q24h Infants and children < 5y: 2.5 mg/kg/dose IV q8h or single daily dosing with normal renal function of 5-7.5 mg/kg/dose IV q24h Children =5y: 2-2.5 mg/kg/dose IV q8h or single daily dosing with normal renal function of 5-7.5 mg/kg/dose IV q24h | Monitor blood levels and kidney function if therapy extends >48 h |
| Note: IM = intramuscular; IV = intravenous; q = every. | ||
| Antibacterial Agent | Daily Dosage |
| Sulfisoxazole | 120-150 mg/kg divided q4-6h |
| Sulfamethoxazole and trimethoprim | 6-12 mg/kg TMP, 30-60 mg/kg SMZ divided q12h |
| Amoxicillin and clavulanic acid | 20-40 mg/kg divided q8h |
| Cephalexin | 20-50 mg/kg divided q6h |
| Cefixime | 8 mg/kg divided q12-24h |
| Cefpodoxime | 10 mg/kg divided q12h |
| Nitrofurantoin* | 5-7 mg/kg divided q6h |
| *Nitrofurantoin may be used to treat lower UTIs. However, because of its limited tissue penetration, nitrofurantoin is not suitable for the treatment of kidney infection. | |
| Agent | Single Daily Dose |
| Nitrofurantoin* | 1-2 mg/kg PO |
| Sulfamethoxazole and trimethoprim* | 1-2 mg/kg TMP, 5-10 mg/kg SMZ PO |
| Trimethoprim | 1-2 mg/kg PO |
| *Do not use nitrofurantoin or sulfa drugs in infants younger than 6 weeks. Reduced doses of an oral, first-generation cephalosporin, such as cephalexin at 10 mg/kg, may be used until the child reaches age 6 weeks. Ampicillin or amoxicillin are not recommended, because of the high incidence of resistant E coli. | |

